Scenesse FDA Trials for Vitiligo episode artwork

EPISODE · May 7, 2011 · 25 MIN

Scenesse FDA Trials for Vitiligo

from Understanding Vitiligo: Insights, Research, and Hope

Nathalie Pelletier speaks with  Lachlan Hay, Head of Global Network and Communications at Clinuvel AG, and he explains exactly how Scenesse works on vitiligo and thoroughly unravels the FDA trial process which Scenesse will undergo. He also gives us an informative background on Clinuvel, the developers of Scenesse, and describes the stipulations and process one needs to know in order to be a part of the FDA trials for Scenesse.

Episode metadata supplied by the publisher feed · Published May 7, 2011

Embed this episode

NOW PLAYING

Scenesse FDA Trials for Vitiligo

0:00 25:21

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Understanding Vitiligo: Insights, Research, and Hope?

This episode is 25 minutes long.

When was this Understanding Vitiligo: Insights, Research, and Hope episode published?

This episode was published on May 7, 2011.

Can I download this Understanding Vitiligo: Insights, Research, and Hope episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!